Dr. Tim Inglis is a clinical microbiologist in Perth, Western Australia, where he leads a translational biomedical research team. In recent years, collaborating with Dr Christine Carson and Dr Kieran Mulroney, the research team have developed a method of rapidly detecting antimicrobial effects that aligns closely with the current reference standard; the broth microdilution method of determining minimum inhibitory concentration. Dr Inglis is Head of the Division of Pathology and Laboratory Medicine at the University of Western Australia, a consultant microbiologist with PathWest Laboratory Medicine, and co-founder of Lab Without Walls, a not-for-profit organization that develops pathology capability for rural, remote and regional communities. His ENCOMPASS Consortium has entered for the UK Longitude Prize, and has attracted support from the Bill and Melinda Gates Foundation. In a collaboration between the University of Western Australia, PathWest Laboratory Medicine WA, and the Harry Perkins Institute of Medical Research, the team has enjoyed recent funding success from Australia's National Health and Medical Research Council to demonstrate the power of their new diagnostic methods to generate actionable results for serious invasive infections.